Licensed Bacille Calmette-Guerin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation

There is no fulltext present in this item.

Title:	Licensed Bacille Calmette-Guerin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation
Author(s):	Angelidou, Asimenia; Conti, M.; Diray-Arce, Joann; Benn, C.S.; Shann, F.; Netea, M.G. ; Haren, S.D. van; Levy, Ofer
Publication year:	2020
Source:	Vaccine, vol. 38, iss. 9, (2020), pp. 2229-2240
ISSN:	0264-410X
DOI:	https://doi.org/10.1016/j.vaccine.2019.11.060
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/217575
Display more details
Subject:	All institutes and research themes of the Radboud University Medical Center Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life Sciences Tijdelijke code tbv inlezen publicaties Radboudumc - Alleen voor gebruik door Radboudumc
Organization:	Internal Medicine
Journal title:	Vaccine
Volume:	vol. 38
Issue:	iss. 9
Page start:	p. 2229
Page end:	p. 2240